CNN reported Monday that two Americas infected with the deadly Ebola virus are recovering thanks to an experimental drug from a San Diego biotech company.

Quoting sources, the network said three top secret, experimental vials were flown into Liberia last week in an effort to save two American missionary workers who had contracted Ebola.

Mapp Biopharmaceutical, based in Mira Mesa, has been developing an Ebola-specific antibody drug called MB-003 in collaboration with the National Institutes of  Health and the Defense Threat Reduction Agency.

The company was founded in 2003 to develop pharmaceuticals for the prevention and treatment of infectious diseases, according to its website.

The experimental drug had been successfully tested on monkeys, but never on humans, CNN said. The company said in a 2013 press release that in tests 43 percent of infected monkeys recovered after receiving the treatment intravenously.

Chris Jennewein

Chris Jennewein is Editor & Publisher of Times of San Diego.